Clinical trials
Terminated Attention Deficit Disorder with Hyperactivity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 3 |
| Massachusetts General Hospital | 3 |
| Supernus Pharmaceuticals, Inc. | 3 |
| Florida International University | 2 |
| Milton S. Hershey Medical Center | 2 |
| Neurocentria, Inc. | 2 |
| New York State Psychiatric Institute | 2 |
| Purdue Pharma LP | 2 |
| Abbott | 1 |
| Alcobra Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 45 |
| Autism Spectrum Disorder | 3 |
| Autistic Disorder | 2 |
| Brain Injuries, Traumatic | 2 |
| Spasm | 2 |
| Attention Deficit and Disruptive Behavior Disorders | 1 |
| Bipolar Disorder | 1 |
| Cocaine-Related Disorders | 1 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.